ADRB3 and bronchopulmonary dysplasia: More generally, the β3-AR agonism could represent a new pharmacological approach to promote organ maturation in prematurity-related diseases (bronchopulmonary dysplasia, retinopathy of prematurity, necrotizing enterocolitis, periventricular leukomalacia).